Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Fox Communications

- PMLiVE

Novo Nordisk and Valo Health expand alliance for cardiometabolic diseases

The partners are aiming to develop new drugs for type 2 diabetes, obesity and cardiovascular disease

- PMLiVE

Eli Lilly announces $3bn expansion to US injectables manufacturing facility

The investment will help Lilly meeting the growing demand for its diabetes and obesity medicines

- PMLiVE

Amgen’s investigational weight-loss drug MariTide shows promise in mid-stage study

The company has announced a phase 3 programme across obesity and related conditions

- PMLiVE

Eli Lilly and HAYA Therapeutics enter metabolic condition partnership worth $1bn

The companies will aim to discover regulatory genome targets for obesity and related metabolic conditions

- PMLiVE

Eli Lilly’s GIP/GLP-1 receptor agonist tirzepatide shown to significantly reduce type 2 diabetes risk

More than 5.6 million people in the UK are estimated to be living with a form of diabetes

- PMLiVE

Eli Lilly’s GIP/GLP-1 receptor agonist tirzepatide shows promise in phase 3 heart failure study

Almost 60% of those affected by HFpEF in the US are also living with obesity

- PMLiVE

JCVI announces advice for autumn COVID-19 vaccination programme eligibility

The Committee has advised offering the vaccine to those at high risk of serious disease

- PMLiVE

Pfizer to advance once-daily formulation of oral GLP-1 receptor agonist danuglipron

The drugmaker said last year that it would be dropping its twice-daily formulation of the candidate

- PMLiVE

ISID establishes six global infectious disease priorities to be addressed at 2024 congress

Involving health and community leaders, the ISID congress will commence in South Africa in December

- PMLiVE

Pfizer/Flagship’s drug discovery partnership to focus on obesity treatments

The agreement with Profound Therapeutics is the first to be initiated under the partnership

- PMLiVE

Getting in-sync with Public Health at SYNC 2024

Medscape Education is bringing its public health efforts to Washington, DC for the SYNC conference on HIV, HCV, STIs, Harm Reduction, and LGBTQ health. During the conference, Lindsey will present...

Medscape Education

Top 10 HEOR trends – A detailed look at ISPOR’s 2024–2025 topics

Top 10 HEOR trends – A detailed look at ISPOR’s 2024–2025 topics

Specialists from across Mtech Access to look at each of ISPOR’s top 10 HEOR trends for 2024–2025. Jump in as the Mtech Access experts give their hot take on each...

Petauri Evidence

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links